The Negative Pressure Wound Therapy Market Size was valued at USD 2.47 Bn in 2023 and is predicted to reach USD 4.11 Bn by 2031 at a 6.8% CAGR during the forecast period for 2024-2031.
Negative pressure wound therapy uses controlled negative pressure to remove extra fluid from open wounds through a sealed or foam dressing that is linked to a collection container. It is a noninvasive method. A number of factors are driving the expansion of the negative pressure wound therapy industry, including the increasing number of people with diabetes, the number of people with serious diseases, and the rising aging population. Additionally, the worldwide need for negative pressure wound care is being driven by a multitude of factors, including the rising incidence of surgical site infections and the increasing number of surgeries performed. However, strict rules regarding negative pressure wound therapy are anticipated to impede the expansion of this industry. The developments in handheld devices, growing healthcare networks in developing nations, heightened knowledge of cutting-edge wound care solutions, and ongoing development of novel and improved negative pressure wound therapy are propelling market expansion.
However, the presence of more affordable alternatives to negative pressure wound therapy for treating both acute and chronic wounds could slow down their acceptance and, in turn, the market growth of negative pressure wound therapy during the predicted timeframe. Additionally, COVID-19 caused a decline in hospital visits and a delay in elective surgeries, which in turn dampened the demand for negative pressure wound therapy. After the pandemic, however, demand rose again because of improvements in home nursing and efforts to manage chronic wounds better. Furthermore, the anticipated expansion of the negative pressure wound therapy market is fueled by the rising number of surgical procedures performed globally, which in turn leads to a larger patient population that has surgical wounds.
Competitive Landscape
Some of the Major Key Players in the Negative Pressure Wound Therapy Market are
- 3M
- Alleva Medical
- Cardinal Health
- Carilex Medical
- Convatech Group
- Cork Medical
- Deroyal
- Genadyne Biotechnologies
- Haromed Medical Technologies
- Medela
- Molnlcke Healthcare
- Paul Hartmann AG
- Pensar Medical
- Smith & Nephew
- Talley Group
- Others
Market Segmentation:
The negative pressure wound therapy market is segmented based on product type, wound type, and end-user. By product type, it is divided into conventional NPWT devices, disposable NPWT devices, and NPWT accessories. By wound type, it is divided into burns and surgical open wounds, pressure ulcers, diabetic foot ulcers, venous leg ulcers, and traumatic wounds. By end-user, it is divided into home care settings, hospitals, and others.
Based on the Product Type, the Disposable NPWT Devices Segment is Accounted as a Major Contributor to the Negative Pressure Wound Therapy Market
The disposable NPWT devices in the negative pressure wound therapy category are expected to hold a major global market share in 2023 because they are easy to use, inexpensive, and less likely to spread germs. Home care and outpatient settings are better suited for these devices because they are great for single use. Additionally, they are becoming increasingly popular and widely used in both established and emerging healthcare markets because of their lightweight and portable nature, which also improves patient mobility.
Hospitals Segment to Witness Growth at A Rapid Rate
The hospital market is expected to grow rapidly in the negative pressure wound therapy market because of the spike in instances involving complicated procedures and chronic wounds that necessitate cutting-edge medical attention. Hospitals provide specialist care and have access to state-of-the-art negative pressure wound therapy, which improves wound management. The growth of this market is being driven by factors such as investments in hospital infrastructure and rising medical expenses.
In the Region, the North American Negative Pressure Wound Therapy Market Holds a Significant Revenue Share
The North American negative pressure wound therapy market is anticipated to register the highest market share in revenue in the near future because of its advanced healthcare system, an increasing number of elderly residents, high rate of chronic wounds, and robust government funding for cutting-edge wound care therapies. In addition, the Asia-Pacific region is expected to grow quickly in the global negative pressure wound therapy market due to the increased frequency of diabetes and the dramatic increase in healthcare costs in the area. Moreover, the negative pressure wound therapy market in Asia-Pacific is growing for a number of reasons, one of which is the large number of patients suffering from chronic diseases.
Recent Developments:
- In May 2024, 3M Health Care’s Medical Solutions Division, a frontrunner in advanced wound care, was granted $34.2 million by the U.S. Army Medical Research Acquisition Activity to create innovative solutions for wound healing, infection prevention, and wound management.
- In April 2024, The Medical Solutions Division of 3M Health Care revealed that their 3MTM V.A.C. Therapy negative pressure wound therapy (NPWT) has more than doubled the number of peer-reviewed medical journal papers that have previously demonstrated its effectiveness. There has never been an NPWT solution with as much published research on its therapy as V.A.C. Therapy. More than three-quarters of all NPWT clinical evidence is based on one brand, making it the most data-backed option available.
- In September 2024, Alleva Medical is thrilled to announce that the FDA has green-lit their groundbreaking Extricate 3000 pumps for residential usage in the US. The Extricate 3000 pump is an advanced device for negative pressure wound therapy that offers patients a wide range of options for successful and flexible wound care.
Negative Pressure Wound Therapy Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 2.47 Bn |
|
Revenue Forecast In 2031 |
USD 4.11 Bn |
|
Growth Rate CAGR |
CAGR of 6.8% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, By Wound Type, By End User and By Region |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
3M, Alleva Medical, Cardinal Health, Carilex Medical, Convatech Group, Cork Medical, Deroyal, Genadyne Biotechnologies, Haromed Medical Technologies, Medela, Molnlycke Healthcare, Paul Hartmann AG, Pensar Medical, Smith & Nephew, Talley Group, and others. |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
